Related Experiment Video
Updated: Feb 24, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Nuclear FAK and Runx1 Cooperate to Regulate IGFBP3, Cell-Cycle Progression, and Tumor Growth
Marta Canel1,2, Adam Byron1, Andrew H Sims1
1Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Abstract:
Nuclear focal adhesion kinase (FAK) is a potentially important regulator of gene expression in cancer, impacting both cellular function and the composition of the surrounding tumor microenvironment. Here, we report in a murine model of skin squamous cell carcinoma (SCC) that nuclear FAK regulates Runx1-dependent transcription of insulin-like growth factor binding protein 3 (IGFBP3), and that this regulates SCC cell-cycle progression and tumor growth in vivo Furthermore, we identified a novel molecular complex between FAK and Runx1 in the nucleus of SCC cells and showed that FAK interacted with a number of Runx1-regulatory proteins, including Sin3a and other epigenetic modifiers known to alter Runx1 transcriptional function through posttranslational modification. These findings provide important new insights into the role of FAK as a scaffolding protein in molecular complexes that regulate gene transcription. Cancer Res; 77(19); 5301-12. ©2017 AACR.
Insights
Nuclear focal adhesion kinase (FAK) regulates gene expression in skin cancer. This study reveals FAK’s role in a novel molecular complex controlling tumor growth and cell-cycle progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Nuclear focal adhesion kinase (FAK) is implicated in cancer gene expression.
- FAK influences cellular function and the tumor microenvironment.
Purpose of the Study:
- Investigate the role of nuclear FAK in skin squamous cell carcinoma (SCC).
- Elucidate the mechanism by which FAK regulates SCC cell-cycle progression and tumor growth.
Main Methods:
- Utilized a murine model of skin SCC.
- Identified and characterized a novel molecular complex involving FAK and Runx1 in SCC cell nuclei.
- Analyzed FAK interactions with Runx1-regulatory proteins and epigenetic modifiers.
Main Results:
- Nuclear FAK was found to regulate Runx1-dependent transcription of insulin-like growth factor binding protein 3 (IGFBP3).
- This regulation impacts SCC cell-cycle progression and tumor growth in vivo.
- A novel FAK-Runx1 molecular complex was identified, interacting with epigenetic modifiers like Sin3a.
Conclusions:
- FAK acts as a scaffolding protein within nuclear molecular complexes that control gene transcription.
- These findings offer new insights into FAK's function in regulating gene expression and tumor progression in SCC.
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

